Skip to main content
Journal of Hematology & Oncology logoLink to Journal of Hematology & Oncology
. 2022 Jul 31;15:102. doi: 10.1186/s13045-022-01323-2

Correction: hUC-EVs-ATO reduce the severity of acute GVHD by resetting inflammatory macrophages toward the M2 phenotype

Yan Su 1,2,3,4,#, Xueyan Sun 1,2,3,4,#, Xiao Liu 1,2,3,4, Qingyuan Qu 1,2,3,4, Liping Yang 1,2,3,4, Qi Chen 1,2,3,4, Fengqi Liu 1,2,3,4, Yueying Li 5,6, Qianfei Wang 5,6, Bo Huang 7, Xiao-Hui Zhang 1,2,3,4,, Xiao-Jun Huang 1,2,3,4,
PMCID: PMC9339190  PMID: 35909099

Correction to: Journal of Hematology & Oncology (2022) 15:99 10.1186/s13045-022-01315-2

The original article [1] contained errors in the names of co-authors, Xiao-Jun Huang and Xiao-Hui Zhang which have since been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Yan Su and Xueyan Sun have contributed equally to this work

Contributor Information

Xiao-Hui Zhang, Email: xjhrm@medmail.com.cn.

Xiao-Jun Huang, Email: zhangxh@bjmu.edu.cn.

Reference

  • 1.Su Y, Sun X, Liu X, et al. hUC-EVs-ATO reduce the severity of acute GVHD by resetting inflammatory macrophages toward the M2 phenotype. J Hematol Oncol. 2022;15:99. doi: 10.1186/s13045-022-01315-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Hematology & Oncology are provided here courtesy of BMC

RESOURCES